The Past, Present, and Future of a Human T-Cell Leukemia Virus Type 1 Vaccine

Human T-cell leukemia virus type 1 (HTLV-1) is an oncogenic human retrovirus which causes a lifelong infection. An estimated 5–10 million persons are infected with HTLV-1 worldwide – a number which is likely higher due to lack of reliable epidemiological data. Most infected individuals remain asympt...

Full description

Saved in:
Bibliographic Details
Main Authors: Joshua J. Tu, Victoria Maksimova, Lee Ratner, Amanda R. Panfil
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Microbiology
Subjects:
HTLV-1
vaccine
envelope
retrovirus
glycoprotein
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2022.897346/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items